Mwe Chao

Hematology | Oncology

111 Michigan Ave NW
Washington, DC 20010

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.

Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.

Journal: Nature communications

Published: May 07, 2025

Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm.

Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm.

Journal: British journal of haematology

Published: September 06, 2024

Correction: Congenital Transcobalamin II Deficiency: A Rare Entity with a Broad Differential.

Correction: Congenital Transcobalamin II Deficiency: A Rare Entity with a Broad Differential.

Journal: Klinische Padiatrie

Published: December 19, 2018

Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms.

Mutational Spectrum of Fanconi Anemia Associated Myeloid Neoplasms.

Journal: Klinische Padiatrie

Published: November 14, 2017

Congenital Transcobalamin II Deficiency: A Rare Entity with a Broad Differential.

Congenital Transcobalamin II Deficiency: A Rare Entity with a Broad Differential.

Journal: Klinische Padiatrie

Published: November 14, 2017

A plea to provide best evidence in trials under sample-size restrictions: the example of pioglitazone to resolve leukoplakia and erythroplakia in Fanconi anemia patients.

A plea to provide best evidence in trials under sample-size restrictions: the example of pioglitazone to resolve leukoplakia and erythroplakia in Fanconi anemia patients.

Journal: Orphanet journal of rare diseases

Published: March 06, 2017

A common ancestral DNMT3A-mutated preleukemic clone giving rise to AML and MDS in an adolescent girl.

A common ancestral DNMT3A-mutated preleukemic clone giving rise to AML and MDS in an adolescent girl.

Journal: Leukemia & lymphoma

Published: November 29, 2016

Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.

Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany.

Journal: Pediatric hematology and oncology

Published: February 23, 2016

Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia.

Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia.

Journal: Klinische Padiatrie

Published: May 19, 2015

Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.

Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.

Journal: Bone marrow transplantation

Published: December 23, 2014

Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.

Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only.

Journal: Annals of hematology

Published: December 14, 2014

Hematological complications of neonatal lupus: case report and review of the literature.

Hematological complications of neonatal lupus: case report and review of the literature.

Journal: Journal of pediatric hematology/oncology

Published: November 07, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026